Following reports of shortages of 300mg lamivudine tablets, the Department of Health has assured the public there is no stock out of the antiretroviral (ARV) and issued clinician guidance regarding the formulation, which will no longer be offered on tender.
After months of erratic supply of its antiretroviral (ARV) Aluvia in South Africa, international pharmaceutical company AbbVie will now allow generic manufacturers to produce the drug to help safeguard supplies, according to an announcement made today.
The latest UNAIDS report notes 15.8 million people were on antiretrovirals as of June and encourages more countries to heed the World Health’s Organisation’s call to roll out the “test and treat” approach.
In an effort to combat medicine shortages, South Africa will roll out a first of its kind early warning system to identify drug stock outs before they happen. The move comes as country and makers of the antiretroviral Aluvia work to address shortages
As public debate rages about whether there are or are not antiretroviral (ARV) stock outs in the county, our rural doctor and blogger reminds us what three letters and ARV stock outs really mean.
South Africa may join just ten countries in the world that provide antiretrovirals (ARVs) to people living with HIV upon diagnosis as new research spurs activists to demand immediate treatment for all people living with HIV.